000 | 01129 a2200349 4500 | ||
---|---|---|---|
005 | 20250517055338.0 | ||
264 | 0 | _c20160726 | |
008 | 201607s 0 0 eng d | ||
022 | _a1875-8630 | ||
024 | 7 |
_a10.1155/2015/316739 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGoričar, Katja | |
245 | 0 | 0 |
_aSerum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma. _h[electronic resource] |
260 |
_bDisease markers _c2015 |
||
300 |
_a316739 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInhibitor of Apoptosis Proteins _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMesothelioma _xblood |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aSurvivin |
700 | 1 | _aKovač, Viljem | |
700 | 1 | _aFranko, Alenka | |
700 | 1 | _aDodič-Fikfak, Metoda | |
700 | 1 | _aDolžan, Vita | |
773 | 0 |
_tDisease markers _gvol. 2015 _gp. 316739 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1155/2015/316739 _zAvailable from publisher's website |
999 |
_c25338638 _d25338638 |